Cargando…

The Efficacy and Immunomodulatory Effects of Ulinastatin and Thymosin α1 for Sepsis: A Systematic Review and Meta-Analysis

Objective. To systematically review the efficacy and potential immunomodulatory effect of ulinastatin combined with thymosin α1 (UTI) for sepsis. Design. A systematic review and meta-analysis of randomized controlled trials (RCTs). Data Sources. The following databases: PubMed, Embase, and Cochrane...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Feng Yun, Fang, Bin, Qiang, Xin Hua, Yu, Tie Ou, Zhong, Jia Rong, Cao, Jun, Zhou, Li Xin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2016
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4906180/ https://www.ncbi.nlm.nih.gov/pubmed/27340674 http://dx.doi.org/10.1155/2016/9508493

Ejemplares similares

The efficacy of thymosin α1 as immunomodulatory treatment for sepsis: a systematic review of randomized controlled trials
por: Liu, Fang, et al.
Publicado: (2016)

Ulinastatin and Thymosin a1 Therapy in Adult Patients with Severe Sepsis: A Meta-analysis with Trial Sequential Analysis of Randomized Controlled Trials
por: FAN, Heng, et al.
Publicado: (2016)

Beneficial effects of ulinastatin on gut barrier function in sepsis
por: Jiang, Longyuan, et al.
Publicado: (2013)

Ulinastatin Ameliorates Pulmonary Capillary Endothelial Permeability Induced by Sepsis Through Protection of Tight Junctions via Inhibition of TNF-α and Related Pathways
por: Fang, Ming, et al.
Publicado: (2018)

Integrated Single Cell and Bulk RNA-Seq Analysis Revealed Immunomodulatory Effects of Ulinastatin in Sepsis: A Multicenter Cohort Study
por: Chen, Lin, et al.
Publicado: (2022)

The efficacy of thymosin alpha 1 for severe sepsis (ETASS): a multicenter, single-blind, randomized and controlled trial
por: Wu, Jianfeng, et al.
Publicado: (2013)

Protective effect of rhubarb combined with ulinastatin for patients with sepsis
por: Meng, Fulei, et al.
Publicado: (2020)

A retrospective study of ulinastatin for the treatment of severe sepsis
por: Meng, Chao, et al.
Publicado: (2020)

The effects of Xuebijing injection combined with ulinastatin as adjunctive therapy on sepsis: An overview of systematic review and meta-analysis
por: Zhong, Guofu, et al.
Publicado: (2022)

The effect of ulinastatin on sepsis in the rats of adhesion molecules and endothelial function
por: Hao, X, et al.
Publicado: (2015)

Combination of Glutamine and Ulinastatin Treatments Greatly Improves Sepsis Outcomes
por: Wang, Junyan, et al.
Publicado: (2020)

Efficacy and Safety of Xuebijing Injection Combined With Ulinastatin as Adjunctive Therapy on Sepsis: A Systematic Review and Meta-Analysis
por: Chen, Guochao, et al.
Publicado: (2018)

Improvement of Sepsis Prognosis by Ulinastatin: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
por: Wang, Huifang, et al.
Publicado: (2019)

Efficacy of Xuebijing Combined with Ulinastatin in the Treatment of Traumatic Sepsis and Effects on Inflammatory Factors and Immune Function in Patients
por: Su, Yuanchao, et al.
Publicado: (2022)

Production of N(α)-acetylated thymosin α1 in Escherichia coli
por: Ren, Yuantao, et al.
Publicado: (2011)

Corrigendum: Improvement of Sepsis Prognosis by Ulinastatin: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
por: Wang, Huifang, et al.
Publicado: (2020)

Generation of Mature N(α)-Terminal Acetylated Thymosin α1 by Cleavage of Recombinant Prothymosin α
por: Liu, Bo, et al.
Publicado: (2013)

Efficacy of ulinastatin for the treatment of patients with severe acute pancreatitis
por: Yao, Jian-hui, et al.
Publicado: (2019)

Efficacy of thymosin α1 and interferon α for the treatment of severe acute pancreatitis in a rat model
por: WANG, XIAOQIN, et al.
Publicado: (2015)

Curative efficacy and safety of traditional Chinese medicine xuebijing injections combined with ulinastatin for treating sepsis in the Chinese population: A meta-analysis
por: Xiao, Shi-Hui, et al.
Publicado: (2018)

Effects of ulinastatin and docataxel on breast tumor growth and expression of IL-6, IL-8, and TNF-α
por: Zhao, Xiaoliang, et al.
Publicado: (2011)

Lack of Efficacy of Ulinastatin Therapy During Cardiopulmonary Bypass Surgery
por: Qiu, Yan, et al.
Publicado: (2015)

Ulinastatin reduces postoperative bleeding and red blood cell transfusion in patients undergoing cardiac surgery: A PRISMA-compliant systematic review and meta-analysis
por: Yao, Yun-Tai, et al.
Publicado: (2020)

Treatment of patients with Covid-19 with a high dose of ulinastatin
por: Huang, Hai, et al.
Publicado: (2022)

ADJunctive Ulinastatin in Sepsis Treatment in China (ADJUST study): study protocol for a randomized controlled trial
por: Jiang, Wei, et al.
Publicado: (2018)

Potential Role of Thymosin-α1 Adjuvant Therapy for Glioblastoma
por: Sungarian, Arno, et al.
Publicado: (2009)

Thymosin Beta 4 and Thymosin Beta 10 Expression in Hepatocellular Carcinoma
por: Theunissen, W., et al.
Publicado: (2014)

Clinical Efficacy of Ulinastatin Combined with Meglumine Adenosine Cyclophosphate in the Treatment of Acute Myocardial Infarction
por: Zhang, Zhenying, et al.
Publicado: (2022)

Ulinastatin is effective in reducing mortality for critically ill patients with sepsis: a causal mediation analysis
por: Xu, Qiancheng, et al.
Publicado: (2018)

Ulinastatin protects against sepsis-induced myocardial injury by inhibiting NLRP3 inflammasome activation
por: Qiu, Juanjuan, et al.
Publicado: (2021)

Effect of ulinastatin on the rocuronium-induced neuromuscular blockade
por: Kim, Min Soo, et al.
Publicado: (2012)

Ulinastatin attenuates diabetes-induced cardiac dysfunction by the inhibition of inflammation and apoptosis
por: Wang, Wen-Ke, et al.
Publicado: (2017)

Effect of Urinary Protease Inhibitor (Ulinastatin) on Cardiopulmonary Bypass: A Meta-Analysis for China and Japan
por: Zhang, Yun, et al.
Publicado: (2014)

Effect of ulinastatin combined with mild therapeutic hypothermia on intestinal barrier dysfunction following cardiopulmonary resuscitation in rats
por: Zhang, Fang-Jie, et al.
Publicado: (2019)

Thymosin α1 protects from CTLA-4 intestinal immunopathology
por: Renga, Giorgia, et al.
Publicado: (2020)

Thymosin α1 for COVID-19: Look before You Leap!
por: Divatia, Jigeeshu V
Publicado: (2022)

Effects of ulinastatin and docetaxel on breast cancer invasion and expression of uPA, uPAR and ERK
por: Luo, Jie, et al.
Publicado: (2011)

Impact of thymosin α1 as an immunomodulatory therapy on long-term survival of non-small cell lung cancer patients after R0 resection: a propensity score-matched analysis
por: Guo, Cheng-Lin, et al.
Publicado: (2021)

Intravenous administration of ulinastatin (human urinary trypsin inhibitor) in severe sepsis: a multicenter randomized controlled study
por: Karnad, Dilip R., et al.
Publicado: (2014)

The immunomodulatory function of adenosine in sepsis
por: Zhang, Teng, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_bhe9gk1adlrv294ivct1o57cgu